Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

The PARTNER 3 Low-Risk Randomized Trial

The Evolut Low-Risk Randomized Trial

Status Updates on the Next Generation of Cerebral Protection Devices

Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Patients)

Case 7

Case 6

Case 5

Case 4